Excitotoxicity and Metabolic Changes in Association With Infarct Progression
Stroke2014Vol. 45(4), pp. 1183–1185
Citations Over TimeTop 18% of 2014 papers
Johannes Woitzik, Alexandra Pinczolits, Nils Hecht, Nora Sandow, Michael Scheel, Christoph Drenckhahn, Jens P. Dreier, Peter Vajkoczy
Abstract
Excitotoxic or metabolic impairment was associated with delayed infarct progression and could serve as a treatment target.
Related Papers
- → Microdialysis of GABA and glutamate: Analysis, interpretation and comparison with microsensors(2007)153 cited
- → Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead(1998)66 cited
- → High Extracellular Glutamate and Neuronal Death in Neurological Disorders: Cause, Contribution or Consequence?(1999)62 cited
- → Dearth of glutamate transporters contributes to striatal excitotoxicity(2004)33 cited
- → Aluminum pretreatment impairs the ability of astrocytes to protect neurons from glutamate mediated toxicity(1993)27 cited